Literature DB >> 8647956

Distinctive immune response patterns of human and murine autoimmune sera to U1 small nuclear ribonucleoprotein C protein.

M Satoh1, J J Langdon, K J Hamilton, H B Richards, D Panka, R A Eisenberg, W H Reeves.   

Abstract

The Ul small nuclear ribonucleoprotein (snRNP), a complex of nine proteins with Ul RNA, is a frequent target of autoantibodies in human and murine systemic lupus erythematosus (SLE). Anti-Sm antibodies recognizing the B'/B, D, E, F, and G proteins of Ul snRNPs are highly specific for SLE, and are nearly always accompanied by anti-nRNP antibodies recognizing the Ul snRNP-specific 70K, A, and/or C proteins. Previous studies suggest that human anti-nRNP antibodies recognize primarily the U1-70K and Ul-A proteins, whereas recognition of Ul-C is less frequent. We report here that autoantibodies to U1-C are more common in human autoimmune sera than believed previously. Using a novel immunoprecipitation technique to detect autoantibodies to native Ul-C, 75/78 human sera with anti-nRNP/ Sm antibodies were anti-Ul-C (+). In striking contrast, only 1/65 anti-nRNP/Sm (+) MRL mouse sera of various Igh allotypes was positive. Two of ten anti-nRNP/Sm (+) sera from BALB/c mice with a lupus-like syndrome induced by pristane recognized Ul-C. Thus, lupus in MRL mice was characterized by a markedly lower frequency of anti-U1-C antibodies than seen in human SLE or pristane-induced lupus. The results may indicate different pathways of intermolecular-intrastructural diversification of autoantibody responses to the components of Ul snRNPs in human and murine lupus, possibly mediated by alterations in antigen processing induced by the autoantibodies themselves.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647956      PMCID: PMC507349          DOI: 10.1172/JCI118711

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Clinical manifestations and anti-(U1)snRNP antibodies: a prospective study of 29 anti-RNP antibody positive patients.

Authors:  I Lundberg; U Nyman; I Pettersson; E Hedfors
Journal:  Br J Rheumatol       Date:  1992-12

3.  Physical association of two nuclear antigens and mutual occurrence of their antibodies: the relationship of the SM and RNAprotein (MO) systems in SLE sera.

Authors:  M Mattioli; M Reichlin
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

4.  Anti-RNP monoclonal antibodies derived from a mouse strain with lupus-like autoimmunity.

Authors:  P B Billings; R W Allen; F C Jensen; S O Hoch
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

5.  A one-step purification of membrane proteins using a high efficiency immunomatrix.

Authors:  C Schneider; R A Newman; D R Sutherland; U Asser; M F Greaves
Journal:  J Biol Chem       Date:  1982-09-25       Impact factor: 5.157

6.  Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus.

Authors:  E M Tan; H G Kunkel
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

7.  Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus.

Authors:  M R Lerner; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

8.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

9.  Monoclonal antibodies to nucleic acid-containing cellular constituents: probes for molecular biology and autoimmune disease.

Authors:  E A Lerner; M R Lerner; C A Janeway; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

10.  Presence of anti-Sm reactivity in autoimmune mouse strains.

Authors:  R A Eisenberg; E M Tan; F J Dixon
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

View more
  17 in total

1.  Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-α.

Authors:  Gerson Dierley Keppeke; Minoru Satoh; Maria Lucia Gomes Ferraz; Edward K L Chan; Luís Eduardo C Andrade
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

2.  Prevalence and sociodemographic correlates of antinuclear antibodies in the United States.

Authors:  Minoru Satoh; Edward K L Chan; Lindsey A Ho; Kathryn M Rose; Christine G Parks; Richard D Cohn; Todd A Jusko; Nigel J Walker; Dori R Germolec; Irene Z Whitt; Patrick W Crockett; Brad A Pauley; Jason Y F Chan; Steven J Ross; Linda S Birnbaum; Darryl C Zeldin; Frederick W Miller
Journal:  Arthritis Rheum       Date:  2012-07

3.  Coexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma.

Authors:  M Satoh; M Vazquez-Del Mercado; M E Krzyszczak; Y Li; A Ceribelli; R W Burlingame; T T Webb; E S Sobel; W H Reeves; E K L Chan
Journal:  Lupus       Date:  2011-10-24       Impact factor: 2.911

Review 4.  Features of autoantigens.

Authors:  W H Reeves; M Satoh
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

5.  B-cell tolerance defects in the B6.Aec1/2 mouse model of Sjögren's syndrome.

Authors:  Wenzhao Meng; Yongmei Li; Emily Xue; Minoru Satoh; Ammon B Peck; Philip L Cohen; Robert A Eisenberg; Eline T Luning Prak
Journal:  J Clin Immunol       Date:  2012-02-17       Impact factor: 8.317

6.  Effect of an exogenous trigger on the pathogenesis of lupus in (NZB x NZW)F1 mice.

Authors:  Hideo Yoshida; Minoru Satoh; Krista M Behney; Chee-Gun Lee; Hanno B Richards; Victoria M Shaheen; Jun-Qi Yang; Ram R Singh; Westley H Reeves
Journal:  Arthritis Rheum       Date:  2002-08

7.  Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients.

Authors:  Wendy C Carcamo; Angela Ceribelli; S John Calise; Claire Krueger; Chen Liu; Massimo Daves; Danilo Villalta; Nicola Bizzaro; Minoru Satoh; Edward K L Chan
Journal:  J Clin Immunol       Date:  2012-10-26       Impact factor: 8.317

8.  Autoantibodies to transcription intermediary factor TIF1β associated with dermatomyositis.

Authors:  Minoru Satoh; Jason Y F Chan; Steven J Ross; Yi Li; Yoshioki Yamasaki; Hidehiro Yamada; Monica Vazquez-del Mercado; Marcelo H Petri; Luis J Jara; Miguel A Saavedra; Claudia Cruz-Reyes; Eric S Sobel; Westley H Reeves; Angela Ceribelli; Edward K L Chan
Journal:  Arthritis Res Ther       Date:  2012-04-17       Impact factor: 5.156

9.  Reduced IgG anti-small nuclear ribonucleoprotein autoantibody production in systemic lupus erythematosus patients with positive IgM anti-cytomegalovirus antibodies.

Authors:  Claudia Azucena Palafox Sánchez; Minoru Satoh; Edward Kl Chan; Wendy C Carcamo; José Francisco Muñoz Valle; Gerardo Orozco Barocio; Edith Oregon Romero; Rosa Elena Navarro Hernández; Mario Salazar Páramo; Antonio Cabral Castañeda; Mónica Vázquez Del Mercado
Journal:  Arthritis Res Ther       Date:  2009-02-20       Impact factor: 5.156

10.  High prevalence of autoantibodies to RNA helicase A in Mexican patients with systemic lupus erythematosus.

Authors:  Monica Vázquez-Del Mercado; Claudia A Palafox-Sánchez; Jose F Muñoz-Valle; Gerardo Orozco-Barocio; Edith Oregon-Romero; Rosa E Navarro-Hernández; Mario Salazar-Páramo; Juan Armendariz-Borunda; Jorge I Gámez-Nava; Laura Gonzalez-Lopez; Jason Yf Chan; Edward Kl Chan; Minoru Satoh
Journal:  Arthritis Res Ther       Date:  2010-01-08       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.